Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery

European Journal of Pharmacology

Volumn 333, Issue 2-3, 1997, Pages 191-197

  Randall, Michael D ^a   McCulloch, Audrey I ^a   Kendall, David A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Anandamide; Cannabinoid; Cytochrome P 450 inhibitor; EDHF (endothelium derived hyperpolarizing factor; Endothelium; K+ channel

Indexed keywords

ANANDAMIDE; CARBACHOL; CLOTRIMAZOLE; CYTOCHROME P450 INHIBITOR; ENDOTHELIUM DERIVED RELAXING FACTOR; LEMAKALIM; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; PROADIFEN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; MALE; MESENTERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ANIMALS; ARACHIDONIC ACIDS; BIOLOGICAL FACTORS; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; CLOTRIMAZOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; ENZYME INHIBITORS; MALE; MESENTERIC ARTERIES; MUSCARINIC AGONISTS; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; POLYUNSATURATED ALKAMIDES; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; PROADIFEN; RATS; RATS, WISTAR; TETRAETHYLAMMONIUM; VASODILATION; VASODILATOR AGENTS;

EID: 0030967888     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01137-0     Document Type: Article

References (29)

1. + channels to arachidonic acid-induced endothelium-dependent vasodilation in rat isolated perfused mesenteric arteries. J. Pharmacol. Exp. Ther. 258:1991;452-458.
2. +]: A functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J. Cardiovasc. Pharmacol. 21:1993;423-429.
3. Bauersachs J., Hecker M., Busse R. Display of the characteristics of endothelium-derived hyperpolarising factor by a cytochrome P450-derived arachidonic metabolite in the coronary microcirculation. Br. J. Pharmacol. 113:1994;1548-1553.
4. Campbell W.B., Gebremedhim D., Pratt P.F., Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78:1996;415-423.
5. Cohen R.A., Vanhoutte P.M. Endothelium-dependent hyperpolarization: Beyond nitric oxide and cyclic GMP. Circulation. 92:1995;3337-3349.
6. Corriu C., Feletou M., Canet E., Vanhoutte P.M. Inhibitors of the cytochrome P450-mono-oxygenase and endothelium-dependent hyperpolarization in the guinea-pig isolated carotid artery. Br. J. Pharmacol. 117:1996;607-610.
7. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
8. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
9. Ellis E.F., Moore S.F., Willoughby K.A. Anandamide and Delta9-THC dilation of cerebral arterioles is blocked by indomethacin. Am. J. Physiol. 269:1996;H1859-H1864.
10. Fulton D., Mahboubi K., McGiff J.C., Quilley J. Cytochrome P450-dependent effects of bradykinin in the rat heart. Br. J. Pharmacol. 114:1995;99-102.
11. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
12. Garland C.J., Plane F., Kemp B.K., Cocks T.M. Endothelium-dependent hyperpolarization: A role in the control of vascular tone. Trends Pharmacol. Sci. 16:1995;23-30.
13. Hecker M., Bara A.T., Bauersachs J., Busse R. Characterisation of endothelium-derived hyperpolarising factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol. 481:1994;407-414.
14. G-nitro-L-arginine in pulmonary hypertension. Br. J. Pharmacol. 116:1995;2457-2467.
15. Kilpatrick E.V., Cocks T.M. Evidence for differential roles of nitric oxide (NO) and hyperpolarisation in endothelium-dependent relaxation of pig isolated coronary artery. Br. J. Pharmacol. 112:1994;557-565.
16. + channels in the endothelium of intact rat aorta. J. Physiol. 492:1996;53-60.
17. McCulloch A.I., Bottrill F.E., Randall M.D., Hiley C.R. Characterisation and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br. J. Pharmacol. 120:1997;1431-1438.
18. + channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed. Br. J. Pharmacol. 117:1996;859-866.
19. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
20. Parsons S.J.W., Hill A., Waldron G.J., Plane F., Garland C.J. The relative importance of nitric oxide and nitric oxide-independent mechanisms in the acetylcholine-evoked dilatation of the rat mesenteric bed. Br. J. Pharmacol. 113:1994;1275-1280.
21. Pinto A., Abrahams N.G., Mullane K.M. Arachidonic acid-induced endothelial-dependent relaxation of canine coronary arteries: Contribution of a cytochrome P450 dependent pathway. J. Pharmacol. Exp. Ther. 240:1987;856-863.
22. Randall M.D., Hiley C.R. Effect of phenobarbitone pretreatment upon endothelium-dependent relaxation to acetylcholine in rat superior mesenteric arterial bed. Br. J. Pharmacol. 94:1988;977-983.
23. Randall M.D., Alexander S.P.H., Bennett T., Boyd E.A., Fry J.R., Gardiner S.M., Kemp P.A., McCulloch A.I., Kendall D.A. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun. 229:1996;114-120.
24. Singer H.A., Saye J.A., Peach M.J. Effects of cytochrome P450 inhibitors on endothelium-dependent relaxation in rabbit aorta. Blood Vessels. 21:1984;223-230.
25. Tare M., Parkington H.C., Coleman H.A., Neild T.O., Dusting G.J. Hyperpolarisation and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature. 346:1990;69-71.
26. Taylor S.G., Weston A.H. Endothelium-derived hyperpolarizing factor: A new endogenous inhibitor from vascular endothelium. Trends Pharmacol. Sci. 9:1988;272-274.
27. Taylor W.J., Wolf A., Young J.M. The interaction of amine local anaesthetics with muscarinic receptors. Br. J. Pharmacol. 71:1980;327-335.
28. + channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br. J. Pharmacol. 117:1996;1600-1606.
29. Zygmunt P.M., Edwards G., Weston A.H., Davies S.C., Högestätt E.D. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br. J. Pharmacol. 118:1996;1147-1152.